What role does Metformin play in influencing the long-term risk of cancer recurrence in patients with a history of cancer and what evidence supports these effects?
Gaurav ChauhanContributor
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Metformin may reduce cancer recurrence by influencing insulin levels and cellular metabolism. Studies, including a meta-analysis in *Diabetologia* (2014), suggest it lowers recurrence rates in breast cancer survivors.